dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Alsina Maqueda, Maria |
dc.contributor.author | Diez Garcia, Marc |
dc.contributor.author | Tabernero Caturla, Josep |
dc.date.accessioned | 2022-08-11T11:56:02Z |
dc.date.available | 2022-08-11T11:56:02Z |
dc.date.issued | 2022-03-10 |
dc.identifier.citation | Alsina M, Tabernero J, Diez M. Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond. Cancers. 2022 Mar 10;14(6):1408. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7992 |
dc.description | Cáncer gástrico; Enfoque molecular; Tercera línea de tratamiento |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;14(6) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Estómac - Càncer - Tractament |
dc.subject | Medicaments antineoplàstics - Efectes secundaris |
dc.subject.mesh | Stomach Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Agents |
dc.subject.mesh | /adverse effects |
dc.title | Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers14061408 |
dc.subject.decs | neoplasias gástricas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antineoplásicos |
dc.subject.decs | /efectos adversos |
dc.relation.publishversion | https://doi.org/10.3390/cancers14061408 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Alsina M] Gastrointestinal & Endocrine Tumours Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medical Oncology Department, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), Pamplona, Spain. [Tabernero J, Diez M] Gastrointestinal & Endocrine Tumours Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 35326560 |
dc.identifier.wos | 000775920300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |